Small bowel bacterial overgrowth: Presentation, diagnosis, and treatment

Current Treatment Options in Gastroenterology

Volumn 7, Issue 1, 2004, Pages 19-28

  Singh, Virmeet V ^a   Toskes, Phillip P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTACID AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; CEFALEXIN; CHLORAMPHENICOL; CIPROFLOXACIN; CISAPRIDE; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; MINOCYCLINE; NORFLOXACIN; OCTREOTIDE; PANCREAS ENZYME; PENICILLIN G; PROBIOTIC AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEROTONIN 3 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; TETRACYCLINE; UNINDEXED DRUG;

ANTIBIOTIC THERAPY; BACTERIAL METABOLISM; BACTERIAL OVERGROWTH; CARDIOTOXICITY; CATABOLISM; CELL DAMAGE; CHRONIC DIARRHEA; CLINICAL FEATURE; CLINICAL TRIAL; DIET THERAPY; DRUG ACTIVITY; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE CELL; INTESTINE INFECTION; MACROCYTIC ANEMIA; MALABSORPTION; NUTRIENT; PATHOPHYSIOLOGY; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; SMALL INTESTINE DISEASE; STEATORRHEA; SYMPTOM; WEIGHT REDUCTION;

EID: 3142758654     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0022-4     Document Type: Review

References (63)

1. Gregg CR, Toskes PP: Enteric bacterial flora and small bowel bacterial overgrowth syndrome. In Sleisenger and Fordtran's Gastrointestinal and Liver Disease, edn 7. Edited by Feldman M, Friedman LS, Slesinger MH. Philadelphia: WB Saunders; 2002:1783-1793.
2. Hoffmann JC, Zeitz M: Small bowel disease in the elderly: diarrhoea and malabsorption. Best Pract Res Clin Gastroenterol 2002, 16:17-36.
3. Lewis SJ, Potts LF, Malhotra R, Mountford R: Small bowel bacterial overgrowth in subjects living in residential care homes. Age Aging 1999, 28:181-185.
4. Riordan SM, McIver CJ, Wakefield D, et al.: Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol 1997, 92:47-51.
5. Desai A, Toskes PP: Bacterial overgrowth syndrome. Curr Treat Opt Infect Dis 2003, 5:189-196.
6. Saltzman JR, Kowdley KV, Pedrosa MC, et al.: Bacterial overgrowth without clinical malbsorption in elderly hypochlorhydic patients. Gastroenterology 1994, 106:615-623.
7. Husebye E, Skar V, Hoverstad T, Melby K: Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut 1992, 33:1331-1337.
8. Lewis SJ, Franco S, Young G, O'Keefe SJ: Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther 1996, 10:557-561.
9. Gough A, Andrews D, Bacon PA, Emery P: Evidence of omeprazole-induced small bowel bacterial overgrowth in patients with scleroderma. Br J Rheumatol 1995, 34:976-977.
10. Toskes PP: Small intestinal bacterial overgrowth, including blind loop syndrome. In Infections of the Gastrointestinal Tract, edn 2. Edited by Blaser M, Smith PD, Rardin JI, et al. Philadelphia: Lippincott Williams & Wilkins; 2002:291-300.
11. Levy J: The effects of antibiotic use on gastrointestinal function. Am J Gastroenterol 2000, 95(suppl 1):S8-S10.
12. Riordan SM, McIver CJ, Wakefield D, et al.: Serum immunoglobulin and soluble IL-2 receptor levels in small intestinal overgrowth with indigenous gut flora. Dig Dis Sci 1999, 44:939-944.
13. Kett K, Baklien K, Bakken A, et al.: Intestinal B-cell isotype response in relation to local bacterial load: evidence for imuunoglobulin A subclass adaptation. Gastroenterology 1995, 109:819-825.
14. Riordan SM, McIver CJ, Wakefield D, et al.: Luminal immunity in small-intestinal bacterial overgrowth and old age. Scand J Gastroenterol 1996, 31:1103-1109.
15. Wanitschke R, Ammon HV: Effects of dihydroxy bile acids and hydroxyl fatty acids on the absorption of oleic acid in the human jejunum. J Clin Invest 1978, 61:178-186.
16. Giannella RA, Rout WR, Toskes PP: Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology 1974, 67:965-974.
17. King CE, Toskes PP: Protein-losing enteropathy in the human and experimental rat blind loop syndrome. Gastroenterology 1981, 80:504-509.
18. Saltzman JR, Russell RM: Nutritional consequences of intestinal bacterial overgrowth. Comp Ther 1994, 20:523-530.
19. Welkos SA, Toskes PP, Baer H, et al.: Importance of anaerobic bacteria in the cobalamin malabsorption of experimental rat blind loop syndrome. Gastroenterology 1981, 80:313-320.
20. Justus PG, Fernandez A, Martin JL, et al.: Altered myoelectric activity in the experimental blind loop syndrome. J Clin Invest 1983, 72:1064-1071.
21. Husebye, Skar V, Hoverstad T, et al.: Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology 1995, 109:1078-1089.
22. Rose S, Young MA, Reynolds JC: Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 1998, 27:563-564.
23. Virally-Monod M, Tielmans D, Kevorkian JP, et al.: Chronic diarrhea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab 1998, 23:530-536.
24. Trespi E, Ferrieri A: Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin 1999, 15:47-52.
25. Bauer TM, Schwacha H, Steinbruckner B, et al.: Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002, 97:2364-2370.
26. Bauer TM, Steinbruckner B, Brinkmann FE, et al.: Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001, 96:2962-2967.
27. Casafont Morencos F, de las Heras Castano G, Martin Ramos L, et al.: Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1996, 41:552-556.
28. Toskes PP: The changing nature of small intestine bacterial overgrowth. Curr Gastroenterol Rep 1999, 1:267-268.
29. Morencos FC, de las Heras Castano G, Martin Ramos L, et al.: Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1995, 40:1252-1256.
30. Fried M, Siegrist H, Frei R, et al.: Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994, 35:23-26.
31. Lewis SJ, Franco S, Young G, et al.: Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther 1996, 10:557-561.
32. Smith GM, Chesner IM, Asquith P, Leyland MJ: Small intestinal bacterial overgrowth in patients with chronic lymphocytic leukaemia. J Clin Pathol 1990, 43:57-59.
33. Holt P: Diarrhea and malabsorption in the elderly. Gastroenterol Clin North Am 2001, 30:427-444.
34. Giannella RA, Toskes PP: Gastrointestinal bleeding and iron absorption in the experimental blind loop syndrome. Am J Clin Nutr 1976, 29:754-757.
35. Pimentel M, Chow EJ, Lin HC: Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000, 95:3503-3506.
36. Jones MP, Craig R, Olinger E: Small intestinal bacterial overgrowth is associated with irritable bowel syndrome: the cart lands squarely in front of the horse. Am J Gastroenterol 2001, 96:3204-3205.
37. Riordan SM, McIver CJ, Duncombe VM, et al.: Small intestinal bacterial overgrowth and the irritable bowel syndrome. Am J Gastroenterol 2001, 96:2506-2508.
38. Simren M, Ringstrom G, Agerfarz P, et al.: Small intestinal bacterial overgrowth is not of major importance in the irritable bowel syndrome [abstract]. Gastroenterology 2003, 124(suppl 1):A-163.
39. Kumar A, Forsmark C, Toskes PP: Small bowel bacterial overgrowth, the changing face of an old disease [abstract]. Gastroenlerology 1996, 110:A340.
40. Romagnuolo J, Schiller D, Bailey RJ: Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002, 97:1113-1126.
41. Lewis SJ, Young G, Mann M, et al.: Improvement in specificity of [14C]d-xylose breath test for bacterial overgrowth. Dig Dis Sci 1997, 42:1587-1592.
42. Riordan SM, McIver CJ, Walker BM, et al.: The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996, 91:1795-1803.
43. King CE, Toskes PP, Guilarte TR, et al.: Comparison of one gram 14C-xylose breath test to the 14C-bile acid breath test in patients with small intestine bacterial overgrowth. Dig Dis Sci 1980, 25:53-58.
44. Ferguson J, Walker K, Thomson AB: Limitations in the use of 14C-glycocholate breath and stool bile acid determinations in patients with chronic diarrhea. J Clin Gastroenterol 1986, 8:258-262.
45. Valdovinos M, Camilleri M, Thomforde G, et al.: Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol 1993, 28:963-968.
46. Riordan S, McIver C, Duncombe V, et al.: Factors influencing the 1-gram 14C-D-xylose breath test for bacterial overgrowth. Am J Gastroenterol 1995, 90:1455-1460.
47. King CE, Toskes PP: Comparison of the 1-gram 14C xylose, 10-gram lactulose H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology 1986, 91:1447-1451.
48. Bishop WP: Breath hydrogen testing for small bowel bacterial overgrowth-a lot of hot air? J Pediatr Gastroenterol Nutr 1997, 25:245-246.
49. Corazza GR, Menozzi MG, Strocchi A, et al.: The diagnosis of small bowel bacterial overgrowth: reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990, 98:302-309.
50. MacMahon M, Gibbons N, Mullins E, et al.: Are hydrogen breath tests valid in the elderly? Gerontology 1996, 42:40-45.
51. Wagner D, Bolt D, Currington C, et al.: Clinical utility of the sorbitol breath test (SBT) to detect small intestinal bacterial overgrowth (SIBO) in the elderly [abstract]. Gastroenterology 2003, 124(suppl 1):A-165.
52. Bouhnik Y, Alain S, Attar A, et al.: Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999, 94:1327-1331.
53. Toledo TK, DiPalma JA: Antibiotics are effective in the treatment of bacterial overgrowth-related diarrhea. Am J Gastroenterol 2000, 95:3644-3645.
54. Attar A, Flourie B, Rambaud JC, et al.: Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999, 117:794-797.
55. Wang X, Soltesz V, Axelson J, et al.: Cholecystokinin increases small intestinal motility and reduces enteric bacterial overgrowth and translocation in rats with surgically induced acute liver failure. Digestion 1996, 57:67-72.
56. Pardo A, Bartoli R, Lorenzo-Zuniga V, et al.: Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000, 31:858-863.
57. Madrid AM, Hurtado C, Venegas M, et al.: Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol 2001, 96:1251-1255.
58. Soudah HC, Hasler WL, Owyang C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991, 325:1461-1467.
59. Edmunds MC, Chen JD, Soykan I, et al.: Effect of octreotide on gastric and small bowel motility in patients with gastroparesis. Aliment Pharmacol Ther 1998, 12:167-174.
60. Verne GN, Eaker EY, Hardy E, et al.: Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995, 40:1892-1901.
61. Stotzer PO, Blomberg L, Conway PL, et al.: Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD. Scand J Infect Dis 1996, 28:615-619.
62. Rolfe RD: The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000, 130(suppl 2): 396S-402S.
63. Gregg CR: Enteric bacterial flora and bacterial overgrowth syndrome. Semin Gastrointest Dis 2002, 13:200-209.